Notable Labs Stock

notablelabs.comHealthcareFounded: 2014Funding to Date: $62.12MM

Notable Labs is a translationally focused drug development company that uses a clinically validated, automated compound sensitivity platform to identify and advance novel therapeutic candidates to dramatically reduce the cost and time of the traditional drug development process.

Register for Details

For more details on financing and valuation for Notable Labs, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Notable Labs.

Register Today

Team

Management Team

Matthew De Silva
Co-Founder, Chief Executive Officer & Board Member
Scott Patterson
Vice President of Engineering
Peter Quinzio
Co-Founder, Chief Financial Officer & and Board Member
Diane Heiser Ph.D
Chief Technology Officer & Scientific Co-Founder
Hiroomi Tada Ph.D
Chief Medical Officer
Michael Horowitz
Chief Operating Officer & General Counsel
Lloyd MacKenzie
Chief Development Officer

Board Members

Matthew De Silva
Peter Quinzio
Jim Kim
Builders VC

Other companies like Notable Labs in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$885.01MM

News

Notable -- a company redefining cancer treatment with a clinically validated platform -- announced it raised $40 million in Series B.
After launching its first in-house R&D program last month, cancer drug-testing startup Notable Labs has brought on two biopharma executives to take charge of its clinical operations and drug development work.